| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |